Intratracheal adenovirus-mediated gene transfer is optimal in experimental lung transplantation
- 1 December 2002
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 124 (6) , 1130-1136
- https://doi.org/10.1067/mtc.2002.123702
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Recipient intramuscular gene transfer of active transforming growth factor-β1 attenuates acute lung rejectionThe Annals of Thoracic Surgery, 2001
- Gene and Stem Cell TherapiesJAMA, 2001
- GENE THERAPY AND TRANSPLANTATION1Transplantation, 2000
- Transforming growth factor–β1 gene transfer ameliorates acute lung allograft rejectionThe Journal of Thoracic and Cardiovascular Surgery, 2000
- In vivo adenovirus-mediated endothelial nitric oxide synthase gene transfer ameliorates lung allograft ischemia-reperfusion injuryThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbitsThe Journal of Gene Medicine, 1999
- Gene Transfer Technology in Therapy: Current Applications and Future GoalsThe International Journal of Cell Cloning, 1999
- Toxicological Comparison of E2a-Deleted and First-Generation Adenoviral Vectors Expressingα1-Antitrypsin after Systemic DeliveryHuman Gene Therapy, 1998
- Transient Expression of Genes TransferredIn Vivointo Heart Using First-Generation Adenoviral Vectors: Role of the Immune ResponseHuman Gene Therapy, 1995
- The Basic Science of Gene TherapyScience, 1993